Accretion Pharmaceuticals Limited has informed the Exchange regarding a press release dated September 22, 2025, titled “Secures Malawi cGMP Approval, Paving the Way for Direct Exports and Revenue Growth”. |SUBJECT: Press Release
Accretion Pharmaceuticals Limited has informed the Exchange regarding a press release dated September 22, 2025, titled “Secures Malawi cGMP Approval, Paving the Way for Direct Exports and Revenue Growth”. |SUBJECT: Press Release